AIM
AIM ImmunoTech
18 hedge funds and large institutions have $103K invested in AIM ImmunoTech in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less capital invested
Capital invested by funds: $120K → $103K (-$16.9K)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$51.6K | |
| 2 | +$26.4K | |
| 3 | +$20.9K | |
| 4 |
Jane Street
New York
|
+$20.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.7K |
Top Sellers
| 1 | -$78.6K | |
| 2 | -$383 | |
| 3 | -$32 | |
| 4 |
Morgan Stanley
New York
|
-$1 |
